Retina Gallery ~ Full Sized Retina Images

Puncate Inner Choroidopathy (PIC) and CNVM - 27 year old female 27 year old female with 4 months vision loss in the right eye. She had no subretinal fluid on presentation. Her vision improved from 20/200 to 20/50 with Lucentis. She has multifocal small scars consistent with a prior episode of PIC
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 38527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37927 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 38427 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 41327 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37927 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 40027 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 42627 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 42827 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 44927 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37127 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 43827 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39027 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39427 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37927 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37727 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39027 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37327 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 33927 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 38727 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39827 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 35527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39427 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39827 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39727 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 40327 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 42527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39027 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 36227 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39327 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39327 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 37527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 40527 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 40627 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 40927 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 42227 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 39327 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)	Punctate Inner Choroidopathy and Choroidal Neovascular Membranevaatamisi: 41327 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment) (0 hinnangut)
38 faili 1 lehel

27 year old female with 4 months vision loss in the right eye. She had no subretinal fluid on presentation. Her vision improved from 20/200 to 20/50 with Lucentis. She has multifocal small scars consistent with a prior episode of PIC